Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - March 4, 2025Idorsia Ltd (SIX: IDIA) today announced its financial results for 2024. Business highlights 2024 Viatris collaboration: ...

The Trump administration aims to close the enrollment period for Obamacare health insurance plans on December 15, one month earlier than the current deadline, the agency ...

The treatment of asymptomatic aortic stenosis, the move to composite endpoints in trials, IFR vs FFR and high-frequency low tidal volume ventilation for AF ablation are the topics John Mandrola ...

the first monograph touching on the full range of the artist’s practice. Alongside artworks, many photographed for the first time, are diaries, archive photographs and, surprisingly, portraits ...

Study participants were randomly assigned to receive either a single intravenous (IV) bolus of tenecteplase (n=592) or a 1-hour IV infusion of alteplase (10% administered as an IV bolus over 1 ...

Participants were randomly assigned to 2 groups. The perioperative treatment group received pembrolizumab 200mg intravenously (IV) every 3 weeks (Q3W) for 2 cycles, as neoadjuvant therapy prior to ...

It was credited as being the game that almost killed Tomb Raider, and now, thanks to Aspyr, it’s back to rear its ugly head on the Nintendo Switch in Tomb Raider IV-VI Remastered. This second ...

and the country’s policy priorities in the context of the 2025 Article IV consultation. At the end of the mission, Ms. Sodsriwiboon issued the following statement: “Thanks to the Maldives’ strong ...

CT-P13, intravenous infliximab, developed and manufactured by Celltrion, is the first monoclonal antibody biosimilar therapy and has been the most established biosimilar treatment in the Canadian mark ...

Vedolizumab (Entyvio) is an IRA. This intravenous (IV) medication treats UC that has not responded to other UC treatments and in people who are trying to avoid taking steroids. The infusion ...

Remicade is given by a healthcare professional as an intravenous (IV) infusion (an injection into your vein given over a period of time). An interaction can occur because one substance causes ...